Samuel A. Wickline - Publications

Affiliations: 
Biomedical Engineering Washington University, Saint Louis, St. Louis, MO 
Area:
Biomedical Engineering, Nanotechnology

265 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vargas I, Grabau RP, Chen J, Weinheimer C, Kovacs A, Dominguez-Viqueira W, Mitchell A, Wickline SA, Pan H. Simultaneous Inhibition of Thrombosis and Inflammation Is Beneficial in Treating Acute Myocardial Infarction. International Journal of Molecular Sciences. 24. PMID 37108494 DOI: 10.3390/ijms24087333  0.462
2021 Lockhart JH, VanWye J, Banerjee R, Wickline SA, Pan H, Totary-Jain H. Self-assembled miRNA-switch nanoparticles target denuded regions and prevent restenosis. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33545360 DOI: 10.1016/j.ymthe.2021.01.032  0.302
2021 Hu L, Pan H, Wickline SA. Fluorine (F) MRI to Measure Renal Oxygen Tension and Blood Volume: Experimental Protocol. Methods in Molecular Biology (Clifton, N.J.). 2216: 509-518. PMID 33476021 DOI: 10.1007/978-1-0716-0978-1_31  0.603
2020 Wilson AJ, Zhou Q, Vargas I, Palekar R, Grabau R, Pan H, Wickline SA. Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 2118: 111-120. PMID 32152974 DOI: 10.1007/978-1-0716-0319-2_8  0.4
2019 Strand MS, Krasnick BA, Pan H, Zhang X, Bi Y, Brooks C, Wetzel C, Sankpal N, Fleming T, Goedegebuure SP, DeNardo DG, Gillanders WE, Hawkins WG, Wickline SA, Fields RC. Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles. Oncotarget. 10: 4761-4775. PMID 31413817 DOI: 10.18632/Oncotarget.27109  0.358
2019 Mills KA, Quinn JM, Roach ST, Palisoul M, Nguyen M, Noia H, Guo L, Fazal J, Mutch DG, Wickline SA, Pan H, Fuh KC. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts. Scientific Reports. 9: 4762. PMID 30886159 DOI: 10.1038/S41598-019-41122-3  0.348
2019 Yan H, Duan X, Pan H, Akk A, Sandell LJ, Wickline SA, Rai MF, Pham CTN. Development of a peptide-siRNA nanocomplex targeting NF- κB for efficient cartilage delivery. Scientific Reports. 9: 442. PMID 30679644 DOI: 10.1038/S41598-018-37018-3  0.311
2019 Pan H, Grabau R, Vargas I, Baldwin M, Cara B, Stephenson D, Lindon A, Chalfant C, Wickline S. P702Anti-thrombin nanoparticles for reduce vascular damage and promote functional recovery in acute ischemic kidney injury well after reperfusion European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz747.0307  0.378
2019 Pan H, Lindon A, Grabau R, Dominguez W, Wickline S. P3100Anti-thrombin nanoparticles limit ischemia-reperfusion injury and no-reflow in myocardial infarction European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz745.0176  0.401
2018 Vemuri C, Upadhya GA, Arif B, Jia J, Lin Y, Gaut JP, Fazal J, Pan H, Wickline SA, Chapman WC. Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model. Transplantation Direct. 4: e384. PMID 30234153 DOI: 10.1097/Txd.0000000000000817  0.318
2018 Kabir AU, Lee TJ, Pan H, Berry JC, Krchma K, Wu J, Liu F, Kang HK, Hinman K, Yang L, Hamilton S, Zhou Q, Veis DJ, Mecham RP, Wickline SA, et al. Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis. Jci Insight. 3. PMID 29669933 DOI: 10.1172/Jci.Insight.97349  0.323
2018 James K, Fazal J, Weinheimer C, Pan H, Wickline S. P944Heterogeneity of microvascular damage and barrier disruption in cardiac ischemia-reperfusion injury mapped with perfusable nanoparticles European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy564.P944  0.33
2018 Fazal J, Chen J, Weinheimer C, Kovacs A, Pan H, Wickline S. P4656Thrombin targeted nanoparticles limit ischemia reperfusion injury in acute myocardial infarction European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy563.P4656  0.345
2018 Mills K, Quinn J, Roach S, Palisoul M, Hagemann A, Thaker P, Powell M, Mutch D, Wickline S, Pan H, Fuh K. A novel nanoparticle platform, p5RHH-siAXL, inhibits metastasis in gynecologic serous cancers Gynecologic Oncology. 149: 69-70. DOI: 10.1016/J.Ygyno.2018.04.158  0.361
2017 Moore JK, Chen J, Pan H, Gaut JP, Jain S, Wickline SA. Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy. Magnetic Resonance in Medicine. PMID 29148253 DOI: 10.1002/Mrm.26985  0.51
2017 Thairu MW, Skidmore IH, Bansal R, Nováková E, Hansen TE, Li-Byarlay H, Wickline SA, Hansen AK. Efficacy of RNA interference knockdown using aerosolized short interfering RNAs bound to nanoparticles in three diverse aphid species. Insect Molecular Biology. PMID 28314050 DOI: 10.1111/Imb.12301  0.372
2017 Krasnick B, Strand MS, Bi Y, Goedegebuure PS, Fleming T, Wickline SA, Pan H, Fields RC. Anti-KRAS siRNA nanoparticles for targeted colorectal cancer therapy. Journal of Clinical Oncology. 35: 636-636. DOI: 10.1200/Jco.2017.35.4_Suppl.636  0.352
2017 Strand MS, Pan H, Krasnick B, Zhang X, Goedegebuure PS, Fleming T, DeNardo DG, Gillanders WE, Hawkins WG, Wickline SA, Fields RC. Precision delivery of RAS-inhibiting siRNA to pancreatic cancer via peptide-based nanoparticles. Journal of Clinical Oncology. 35: 287-287. DOI: 10.1200/Jco.2017.35.4_Suppl.287  0.367
2017 Mills K, Palisoul M, Quinn J, Hagemann A, Thaker P, Powell M, Mutch D, Wickline S, Pan H, Fuh K. P5RHH-siAXL nanoparticle is a novel targeted therapy in metastatic gynecologic serous cancers Gynecologic Oncology. 145: 118. DOI: 10.1016/J.Ygyno.2017.03.277  0.388
2016 Yan H, Duan X, Pan H, Holguin N, Rai MF, Akk A, Springer LE, Wickline SA, Sandell LJ, Pham CT. Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury. Proceedings of the National Academy of Sciences of the United States of America. PMID 27681622 DOI: 10.1073/Pnas.1608245113  0.32
2016 Palekar RU, Jallouk AP, Myerson JW, Pan H, Wickline SA. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26769047 DOI: 10.1161/Atvbaha.115.306697  0.713
2016 Strand MS, Pan H, Grossman JG, Goedegebuure PS, Fleming T, Wickline SA, Fields RC. Precision cancer therapy through nanoparticle delivery of siRNA against KRAS. Journal of Clinical Oncology. 34: 260-260. DOI: 10.1200/Jco.2016.34.4_Suppl.260  0.378
2016 Strand M, Pan H, Zhang X, Grossman J, Goedegebuure P, Fleming T, Gillanders WE, Wickline SA, Fields RC. Abstract 1080: Kras downregulation by nanoparticle delivery of siRNA reduces tumor growth in mice Cancer Research. 76: 1080-1080. DOI: 10.1158/1538-7445.Am2016-1080  0.354
2015 Schmieder AH, Caruthers SD, Keupp J, Wickline SA, Lanza GM. Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions. Engineering (Beijing, China). 1: 475-489. PMID 27110430 DOI: 10.15302/J-Eng-2015103  0.407
2015 Esser AK, Schmieder AH, Ross MH, Xiang J, Su X, Cui G, Zhang H, Yang X, Allen JS, Williams T, Wickline SA, Pan D, Lanza GM, Weilbaecher KN. Dual-therapy with αvβ3-targeted Sn2 lipase-labile Fumagillin-prodrug Nanoparticles and Zoledronic Acid in the Vx2 Rabbit Tumor Model. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 26515754 DOI: 10.1016/J.Nano.2015.10.003  0.347
2015 Palekar RU, Vemuri C, Marsh JN, Arif B, Wickline SA. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models. Journal of Vascular Surgery. PMID 26482989 DOI: 10.1016/J.Jvs.2015.08.086  0.352
2015 Pan D, Pham CT, Weilbaecher KN, Tomasson MH, Wickline SA, Lanza GM. Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 26296541 DOI: 10.1002/Wnan.1355  0.354
2015 Pham CT, Pan H, Wickline SA. Peptide-siRNA nanotherapeutics in arthritis. Oncotarget. 6: 14731-2. PMID 26142704 DOI: 10.18632/Oncotarget.4439  0.339
2015 Jallouk AP, Palekar RU, Marsh JN, Pan H, Pham CT, Schlesinger PH, Wickline SA. Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles. Bioconjugate Chemistry. 26: 1640-50. PMID 26083278 DOI: 10.1021/Acs.Bioconjchem.5B00246  0.362
2015 Palekar RU, Jallouk AP, Lanza GM, Pan H, Wickline SA. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents. Nanomedicine (London, England). 10: 1817-32. PMID 26080701 DOI: 10.2217/Nnm.15.26  0.49
2015 Palekar RU, Jallouk AP, Goette MJ, Chen J, Myerson JW, Allen JS, Akk A, Yang L, Tu Y, Miller MJ, Pham CT, Wickline SA, Pan H. Quantifying progression and regression of thrombotic risk in experimental atherosclerosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 3100-9. PMID 25857553 DOI: 10.1096/Fj.14-269084  0.79
2015 Jallouk AP, Palekar RU, Pan H, Schlesinger PH, Wickline SA. Modifications of natural peptides for nanoparticle and drug design. Advances in Protein Chemistry and Structural Biology. 98: 57-91. PMID 25819276 DOI: 10.1016/Bs.Apcsb.2014.12.001  0.331
2015 Wang K, Pan D, Schmieder AH, Senpan A, Hourcade DE, Pham CT, Mitchell LM, Caruthers SD, Cui G, Wickline SA, Shen B, Lanza GM. Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 601-9. PMID 25652900 DOI: 10.1016/J.Nano.2014.12.009  0.439
2015 Chen J, Vemuri C, Palekar RU, Gaut JP, Goette M, Hu L, Cui G, Zhang H, Wickline SA. Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury. American Journal of Physiology. Renal Physiology. 308: F765-73. PMID 25651565 DOI: 10.1152/Ajprenal.00457.2014  0.786
2015 Hughes MS, Marsh JN, Wickline SA, McCarthy JE. Additional results for "joint entropy of continuously differentiable ultrasonic waveforms" [J. Acoust. Soc. Am. 133(1), 283-300 (2013)]. The Journal of the Acoustical Society of America. 137: 501. PMID 25618079 DOI: 10.1121/1.4904531  0.411
2015 Goette MJ, Lanza GM, Caruthers SD, Wickline SA. Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation. Journal of Magnetic Resonance Imaging : Jmri. 42: 488-94. PMID 25425244 DOI: 10.1002/Jmri.24812  0.811
2015 Goette MJ, Keupp J, Rahmer J, Lanza GM, Wickline SA, Caruthers SD. Balanced UTE-SSFP for 19F MR imaging of complex spectra. Magnetic Resonance in Medicine. 74: 537-43. PMID 25163853 DOI: 10.1002/Mrm.25437  0.794
2015 Wagner EM, Jenkins J, Schmieder A, Eldridge L, Zhang Q, Moldobaeva A, Zhang H, Allen JS, Yang X, Mitzner W, Keupp J, Caruthers SD, Wickline SA, Lanza GM. Angiogenesis and airway reactivity in asthmatic Brown Norway rats. Angiogenesis. 18: 1-11. PMID 25149641 DOI: 10.1007/S10456-014-9441-6  0.313
2015 Jallouk A, Palekar R, Pan H, Schlesinger P, Wickline S. Nanoparticle-Bound Cytolytic Peptide Prodrugs for Cancer Therapy The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.620.6  0.362
2014 Myerson JW, He L, Allen JS, Williams T, Lanza G, Tollefsen D, Caruthers S, Wickline S. Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces. Nanotechnology. 25: 395101. PMID 25200815 DOI: 10.1088/0957-4484/25/39/395101  0.728
2014 Hu L, Wickline SA, Hood JL. Magnetic resonance imaging of melanoma exosomes in lymph nodes. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. PMID 25052384 DOI: 10.1002/Mrm.25376  0.587
2014 Bulte JW, Schmieder AH, Keupp J, Caruthers SD, Wickline SA, Lanza GM. MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1385-8. PMID 24832959 DOI: 10.1016/J.Nano.2014.05.001  0.417
2014 Jallouk AP, Moley KH, Omurtag K, Hu G, Lanza GM, Wickline SA, Hood JL. Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity. Plos One. 9: e95411. PMID 24748389 DOI: 10.1371/Journal.Pone.0095411  0.421
2014 Pan D, Schmieder AH, Wang K, Yang X, Senpan A, Cui G, Killgore K, Kim B, Allen JS, Zhang H, Caruthers SD, Shen B, Wickline SA, Lanza GM. Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles. Theranostics. 4: 565-78. PMID 24723979 DOI: 10.7150/Thno.7581  0.393
2014 Bibee KP, Cheng YJ, Ching JK, Marsh JN, Li AJ, Keeling RM, Connolly AM, Golumbek PT, Myerson JW, Hu G, Chen J, Shannon WD, Lanza GM, Weihl CC, Wickline SA. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2047-61. PMID 24500923 DOI: 10.1096/Fj.13-237388  0.785
2014 Pan D, Schirra CO, Wickline SA, Lanza GM. Multicolor computed tomographic molecular imaging with noncrystalline high-metal-density nanobeacons. Contrast Media & Molecular Imaging. 9: 13-25. PMID 24470291 DOI: 10.1002/Cmmi.1571  0.402
2014 Hood JL, Scott MJ, Wickline SA. Maximizing exosome colloidal stability following electroporation. Analytical Biochemistry. 448: 41-9. PMID 24333249 DOI: 10.1016/J.Ab.2013.12.001  0.304
2014 Hu L, Chen J, Yang X, Senpan A, Allen JS, Yanaba N, Caruthers SD, Lanza GM, Hammerman MR, Wickline SA. Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear (1) H/(19) F MRI and perfluorocarbon nanoparticles. Magnetic Resonance in Medicine. 71: 2186-96. PMID 23929727 DOI: 10.1002/Mrm.24851  0.697
2014 Schmieder AH, Wang K, Zhang H, Senpan A, Pan D, Keupp J, Caruthers SD, Wickline SA, Shen B, Wagner EM, Lanza GM. Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging. Angiogenesis. 17: 51-60. PMID 23918207 DOI: 10.1007/S10456-013-9377-2  0.419
2014 Pan H, Myerson J, Yang X, Lanza G, Wickline SA. Atherosclerosis endothelial activation quantification in vivo with fluorine magnetic resonance imaging and spectroscopy Journal of Cardiovascular Magnetic Resonance. 16. DOI: 10.1186/1532-429X-16-S1-O91  0.744
2014 Soodgupta D, Pan D, Cui G, Senpan A, Yang X, Wickline SA, Prochownik EV, Weilbaecher KN, Tomasson MH, Lanza GM. Abstract 5381: VLA-4 targeted nanoparticles deliver a cMYC-MAX prodrug antagonist extends survival a metastatic myeloma mouse model Cancer Research. 74: 5381-5381. DOI: 10.1158/1538-7445.Am2014-5381  0.346
2014 Hughes M, McCarthy J, Marsh J, Wickline S. High sensitivity imaging of resin-rich regions in graphite/epoxy laminates using joint entropy Journal of the Acoustical Society of America. 136: 2282-2282. DOI: 10.1121/1.4900249  0.334
2014 Hughes M, McCarthy J, Marsh J, Wickline S. Optimal smoothing splines improve efficiency of entropy imaging for detection of therapeutic benefit in muscular dystrophy Journal of the Acoustical Society of America. 136: 2264-2264. DOI: 10.1121/1.4900179  0.325
2014 Hughes M, McCarthy J, Marsh J, Wickline S. Entropy based detection of molecularly targeted nanoparticle ultrasound contrast agents in tumors Journal of the Acoustical Society of America. 136: 2095-2095. DOI: 10.1121/1.4899531  0.444
2013 Chen J, Pan H, Lanza GM, Wickline SA. Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy. Advances in Chronic Kidney Disease. 20: 466-78. PMID 24206599 DOI: 10.1053/J.Ackd.2013.08.004  0.571
2013 Palekar RU, Myerson JW, Schlesinger PH, Sadler JE, Pan H, Wickline SA. Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis. Molecular Pharmaceutics. 10: 4168-75. PMID 24063304 DOI: 10.1021/Mp400210Q  0.706
2013 Li-Byarlay H, Li Y, Stroud H, Feng S, Newman TC, Kaneda M, Hou KK, Worley KC, Elsik CG, Wickline SA, Jacobsen SE, Ma J, Robinson GE. RNA interference knockdown of DNA methyl-transferase 3 affects gene alternative splicing in the honey bee. Proceedings of the National Academy of Sciences of the United States of America. 110: 12750-5. PMID 23852726 DOI: 10.1073/Pnas.1310735110  0.688
2013 Schmieder AH, Winter PM, Williams TA, Allen JS, Hu G, Zhang H, Caruthers SD, Wickline SA, Lanza GM. Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles. Radiology. 268: 470-80. PMID 23771914 DOI: 10.1148/Radiol.13120789  0.453
2013 Hou KK, Pan H, Lanza GM, Wickline SA. Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials. 34: 3110-9. PMID 23380356 DOI: 10.1016/J.Biomaterials.2013.01.037  0.368
2013 Hughes MS, McCarthy JE, Marsh JN, Wickline SA. Joint entropy of continuously differentiable ultrasonic waveforms Journal of the Acoustical Society of America. 133: 283-300. PMID 23297902 DOI: 10.1121/1.4770245  0.305
2013 Zhang L, Allen J, Hu L, Caruthers SD, Wickline SA, Chen J. Cardiomyocyte architectural plasticity in fetal, neonatal, and adult pig hearts delineated with diffusion tensor MRI. American Journal of Physiology. Heart and Circulatory Physiology. 304: H246-52. PMID 23161881 DOI: 10.1152/Ajpheart.00129.2012  0.613
2013 Pan H, Myerson JW, Hu L, Marsh JN, Hou K, Scott MJ, Allen JS, Hu G, San Roman S, Lanza GM, Schreiber RD, Schlesinger PH, Wickline SA. Programmable nanoparticle functionalization for in vivo targeting. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 255-64. PMID 23047896 DOI: 10.1096/Fj.12-218081  0.796
2013 Hood JL, Jallouk AP, Campbell N, Ratner L, Wickline SA. Cytolytic nanoparticles attenuate HIV-1 infectivity. Antiviral Therapy. 18: 95-103. PMID 22954649 DOI: 10.3851/Imp2346  0.322
2013 Hu L, Chen J, Yang X, Caruthers SD, Lanza GM, Wickline SA. Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence. Magnetic Resonance in Medicine. 70: 176-83. PMID 22915328 DOI: 10.1002/Mrm.24436  0.67
2013 Watkins MP, Williams TA, Caruthers SD, Wickline SA. Cardiovascular MR function and coronaries: CMR 15 minute express Journal of Cardiovascular Magnetic Resonance. 15. DOI: 10.1186/1532-429X-15-S1-T11  0.335
2013 Goette MJ, Schmieder AH, Williams TA, Allen JS, Keupp J, Lanza GM, Wickline SA, Caruthers SD. Quantitative molecular imaging of angiogenesis-targeted fluorinated nanoparticles: new approaches for B1-mapping compensation for 19F-MRI Journal of Cardiovascular Magnetic Resonance. 15. DOI: 10.1186/1532-429X-15-S1-O83  0.842
2013 Hughes M, McCarthy JE, Marsh JN, Wickline SA. Entropy imaging and nanostructures Journal of the Acoustical Society of America. 134: 4048-4048. DOI: 10.1121/1.4830772  0.391
2012 Zhou HF, Yan H, Senpan A, Wickline SA, Pan D, Lanza GM, Pham CT. Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles. Biomaterials. 33: 8632-40. PMID 22922023 DOI: 10.1016/J.Biomaterials.2012.08.005  0.429
2012 Cheng YJ, Lang D, Caruthers SD, Efimov IR, Chen J, Wickline SA. Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts. American Journal of Physiology. Heart and Circulatory Physiology. 303: H559-68. PMID 22777417 DOI: 10.1152/Ajpheart.00321.2012  0.581
2012 Zhang C, Cheng YJ, Chen J, Wickline S, Wang LV. Label-free photoacoustic microscopy of myocardial sheet architecture. Journal of Biomedical Optics. 17: 060506. PMID 22734729 DOI: 10.1117/1.Jbo.17.6.060506  0.635
2012 Pan D, Sanyal N, Schmieder AH, Senpan A, Kim B, Yang X, Hu G, Allen JS, Gross RW, Wickline SA, Lanza GM. Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug. Nanomedicine (London, England). 7: 1507-19. PMID 22709347 DOI: 10.2217/Nnm.12.27  0.394
2012 Pan D, Schirra CO, Senpan A, Schmieder AH, Stacy AJ, Roessl E, Thran A, Wickline SA, Proska R, Lanza GM. An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging. Acs Nano. 6: 3364-70. PMID 22385324 DOI: 10.1021/Nn300392X  0.333
2012 Pan D, Cai X, Yalaz C, Senpan A, Omanakuttan K, Wickline SA, Wang LV, Lanza GM. Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles. Acs Nano. 6: 1260-7. PMID 22229462 DOI: 10.1021/Nn203895N  0.4
2012 Cai K, Kiefer GE, Caruthers SD, Wickline SA, Lanza GM, Winter PM. Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles. Nmr in Biomedicine. 25: 279-85. PMID 21751273 DOI: 10.1002/Nbm.1746  0.665
2012 Pan D, Caruthers SD, SenPan A, Schmieder AH, Williams TA, Scott MJ, Gaffney PJ, Wickline SA, Lanza G. Thrombus-specific manganese-based “nanobialys” for MR molecular imaging of ruptured plaque Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-P136  0.494
2012 Pan D, Caruthers SD, SenPan A, Scott MJ, Schmieder AH, Gaffney PJ, Wickline SA, Lanza G. Copper nanocolloids: a new thrombus molecular imaging approach to ruptured plaque Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-O42  0.357
2012 Myerson JW, Allen JS, Williams TA, He L, Tollefsen DM, Lanza G, Caruthers SD, Wickline SA. PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-O41  0.719
2012 Cheng Y, Lang D, Caruthers SD, Lanza G, Efimov I, Chen J, Wickline SA. Regional expression of myocardial sheet dysfunction in dystrophin-deficient cardiomyopathy elucidated with diffusion tensor MRI and optical calcium mapping Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-O31  0.592
2012 Wang K, Pan D, Schmieder AH, Zhang H, SenPan A, Williams TA, Hu G, Caruthers SD, Wickline SA, Shen B, Lanza G. Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-O11  0.442
2012 Goette MJ, Schmieder AH, Williams TA, Allen JS, Keupp J, Lanza G, Wickline SA, Caruthers SD. In Vivo quantitative imaging of angiogenesis-targeted PFOB nanoparticles in a hypercholesterol rabbit model using 19F-MRI with ultra-short echo time balanced SSFP Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-M8  0.841
2011 Pan D, Schmieder AH, Wickline SA, Lanza GM. Manganese-based MRI contrast agents: past, present and future. Tetrahedron. 67: 8431-8444. PMID 22043109 DOI: 10.1016/J.Tet.2011.07.076  0.34
2011 Zhang H, Zhang L, Myerson J, Bibee K, Scott M, Allen J, Sicard G, Lanza G, Wickline S. Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents. Plos One. 6: e26385. PMID 22028868 DOI: 10.1371/Journal.Pone.0026385  0.789
2011 Pan D, Pramanik M, Wickline SA, Wang LV, Lanza GM. Recent advances in colloidal gold nanobeacons for molecular photoacoustic imaging. Contrast Media & Molecular Imaging. 6: 378-88. PMID 22025338 DOI: 10.1002/Cmmi.449  0.467
2011 Hu L, Zhang L, Chen J, Lanza GM, Wickline SA. Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endosomal activation. Journal of Magnetic Resonance Imaging : Jmri. 34: 653-61. PMID 21761488 DOI: 10.1002/Jmri.22656  0.674
2011 Hu L, Hockett FD, Chen J, Zhang L, Caruthers SD, Lanza GM, Wickline SA. A generalized strategy for designing (19)F/(1)H dual-frequency MRI coil for small animal imaging at 4.7 Tesla. Journal of Magnetic Resonance Imaging : Jmri. 34: 245-52. PMID 21698714 DOI: 10.1002/Jmri.22516  0.644
2011 Hughes M, Marsh J, Lanza G, Wickline S, McCarthy J, Wickerhauser V, Maurizi B, Wallace K. Improved signal processing to detect cancer by ultrasonic molecular imaging of targeted nanoparticles. The Journal of the Acoustical Society of America. 129: 3756-67. PMID 21682399 DOI: 10.1121/1.3578459  0.399
2011 Myerson J, He L, Lanza G, Tollefsen D, Wickline S. Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis. Journal of Thrombosis and Haemostasis : Jth. 9: 1292-300. PMID 21605330 DOI: 10.1111/J.1538-7836.2011.04339.X  0.743
2011 Pan D, Caruthers SD, Senpan A, Yalaz C, Stacy AJ, Hu G, Marsh JN, Gaffney PJ, Wickline SA, Lanza GM. Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus. Journal of the American Chemical Society. 133: 9168-71. PMID 21599030 DOI: 10.1021/Ja201918U  0.436
2011 Wang Q, Song SK, Zhang H, Berkowitz BA, Chen S, Wickline SA, Chen J. Photoreceptor degeneration changes magnetic resonance imaging features in a mouse model of retinitis pigmentosa. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 65: 1793-8. PMID 21590807 DOI: 10.1002/Mrm.22751  0.426
2011 Buxton DB, Antman M, Danthi N, Dilsizian V, Fayad ZA, Garcia MJ, Jaff MR, Klimas M, Libby P, Nahrendorf M, Sinusas AJ, Wickline SA, Wu JC, Bonow RO, Weissleder R. Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation. 123: 2157-63. PMID 21576680 DOI: 10.1161/Circulationaha.110.000943  0.388
2011 Marsh JN, Hu G, Scott MJ, Zhang H, Goette MJ, Gaffney PJ, Caruthers SD, Wickline SA, Abendschein D, Lanza GM. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine (London, England). 6: 605-15. PMID 21506686 DOI: 10.2217/Nnm.11.21  0.806
2011 Keupp J, Rahmer J, Grässlin I, Mazurkewitz PC, Schaeffter T, Lanza GM, Wickline SA, Caruthers SD. Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents. Magnetic Resonance in Medicine. 66: 1116-22. PMID 21394779 DOI: 10.1002/Mrm.22877  0.383
2011 Pan H, Soman NR, Schlesinger PH, Lanza GM, Wickline SA. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 3: 318-27. PMID 21225660 DOI: 10.1002/Wnan.126  0.396
2011 Sim H, Bibee K, Wickline S, Sept D. Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy. Cancer Research. 71: 686-92. PMID 21123454 DOI: 10.1158/0008-5472.Can-10-2666  0.694
2011 Pan D, Pramanik M, Senpan A, Allen JS, Zhang H, Wickline SA, Wang LV, Lanza GM. Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 875-82. PMID 21097518 DOI: 10.1096/Fj.10-171728  0.404
2011 Pham CT, Mitchell LM, Huang JL, Lubniewski CM, Schall OF, Killgore JK, Pan D, Wickline SA, Lanza GM, Hourcade DE. Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces. The Journal of Biological Chemistry. 286: 123-30. PMID 21047788 DOI: 10.1074/Jbc.M110.180760  0.367
2011 Chen J, Wang Q, Chen S, Wickline SA, Song SK. In vivo diffusion tensor MRI of the mouse retina: a noninvasive visualization of tissue organization. Nmr in Biomedicine. 24: 447-51. PMID 20931570 DOI: 10.1002/Nbm.1609  0.411
2011 Pan H, Ivashyna O, Sinha B, Lanza GM, Ratner L, Schlesinger PH, Wickline SA. Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling. Biomaterials. 32: 231-8. PMID 20864161 DOI: 10.1016/J.Biomaterials.2010.08.080  0.328
2011 Pan D, Caruthers SD, Senpan A, Schmieder AH, Wickline SA, Lanza GM. Revisiting an old friend: manganese-based MRI contrast agents. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 3: 162-73. PMID 20860051 DOI: 10.1002/Wnan.116  0.405
2011 Hockett FD, Wallace KD, Schmieder AH, Caruthers SD, Pham CT, Wickline SA, Lanza GM. Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T. Ieee Transactions On Medical Imaging. 30: 22-7. PMID 20699209 DOI: 10.1109/Tmi.2010.2056689  0.412
2011 Pan D, Schmieder A, Sanyal N, Yang X, Senpan A, Allen J, Zhang H, Wickline S, Lanza G. ENHANCED ANTIANGIOGENIC EFFICACY OF PRODRUG NANOPARTICLES QUANTIFIED WITH MAGNETIC RESONANCE IMAGING Journal of the American College of Cardiology. 57: E1592. DOI: 10.1016/S0735-1097(11)61592-1  0.45
2011 Lanza GM, Caruthers SD, Schmieder AH, Winter PM, Cyrus T, Wickline SA. Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image-Guided Drug Delivery Nanoplatform-Based Molecular Imaging. 725-753. DOI: 10.1002/9780470767047.ch30  0.351
2010 Pan D, Pramanik M, Senpan A, Wickline SA, Wang LV, Lanza GM. A facile synthesis of novel self-assembled gold nanorods designed for near-infrared imaging. Journal of Nanoscience and Nanotechnology. 10: 8118-23. PMID 21121304 DOI: 10.1166/Jnn.2010.3034  0.454
2010 Pan D, Roessl E, Schlomka JP, Caruthers SD, Senpan A, Scott MJ, Allen JS, Zhang H, Hu G, Gaffney PJ, Choi ET, Rasche V, Wickline SA, Proksa R, Lanza GM. Computed tomography in color: NanoK-enhanced spectral CT molecular imaging. Angewandte Chemie (International Ed. in English). 49: 9635-9. PMID 21077082 DOI: 10.1002/Anie.201005657  0.324
2010 Winter PM, Caruthers SD, Lanza GM, Wickline SA. Quantitative cardiovascular magnetic resonance for molecular imaging. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 12: 62. PMID 21047411 DOI: 10.1186/1532-429X-12-62  0.436
2010 Zhou HF, Hu G, Wickline SA, Lanza GM, Pham CT. Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomedicine (London, England). 5: 1065-74. PMID 20874021 DOI: 10.2217/Nnm.10.78  0.391
2010 Cai K, Caruthers SD, Huang W, Williams TA, Zhang H, Wickline SA, Lanza GM, Winter PM. MR molecular imaging of aortic angiogenesis. Jacc. Cardiovascular Imaging. 3: 824-32. PMID 20705262 DOI: 10.1016/J.Jcmg.2010.03.012  0.576
2010 Winter PM, Caruthers SD, Allen JS, Cai K, Williams TA, Lanza GM, Wickline SA. Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles. Magnetic Resonance in Medicine. 64: 369-76. PMID 20665780 DOI: 10.1002/Mrm.22447  0.638
2010 Akers WJ, Zhang Z, Berezin M, Ye Y, Agee A, Guo K, Fuhrhop RW, Wickline SA, Lanza GM, Achilefu S. Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles. Nanomedicine (London, England). 5: 715-26. PMID 20662643 DOI: 10.2217/Nnm.10.38  0.426
2010 Lanza GM, Caruthers SD, Winter PM, Hughes MS, Schmieder AH, Hu G, Wickline SA. Angiogenesis imaging with vascular-constrained particles: the why and how. European Journal of Nuclear Medicine and Molecular Imaging. 37: S114-26. PMID 20617434 DOI: 10.1007/S00259-010-1502-5  0.386
2010 Kassner A, Thornhill RE, Liu F, Winter PM, Caruthers SD, Wickline SA, Lanza GM. Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model. Contrast Media & Molecular Imaging. 5: 155-61. PMID 20586031 DOI: 10.1002/Cmmi.380  0.333
2010 Boles KS, Schmieder AH, Koch AW, Carano RA, Wu Y, Caruthers SD, Tong RK, Stawicki S, Hu G, Scott MJ, Zhang H, Reynolds BA, Wickline SA, Lanza GM. MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 4262-70. PMID 20585027 DOI: 10.1096/Fj.10-157933  0.454
2010 Chen J, Lanza GM, Wickline SA. Quantitative magnetic resonance fluorine imaging: today and tomorrow. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 2: 431-40. PMID 20564465 DOI: 10.1002/Wnan.87  0.507
2010 Pan D, Caruthers SD, Chen J, Winter PM, SenPan A, Schmieder AH, Wickline SA, Lanza GM. Nanomedicine strategies for molecular targets with MRI and optical imaging. Future Medicinal Chemistry. 2: 471-90. PMID 20485473 DOI: 10.4155/Fmc.10.5  0.548
2010 Lanza GM, Winter PM, Caruthers SD, Hughes MS, Hu G, Schmieder AH, Wickline SA. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions Angiogenesis. 13: 189-202. PMID 20411320 DOI: 10.1007/s10456-010-9166-0  0.347
2010 Pan H, Myerson JW, Ivashyna O, Soman NR, Marsh JN, Hood JL, Lanza GM, Schlesinger PH, Wickline SA. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 2928-37. PMID 20335225 DOI: 10.1096/Fj.09-153130  0.734
2010 Pan D, Pramanik M, Senpan A, Ghosh S, Wickline SA, Wang LV, Lanza GM. Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. Biomaterials. 31: 4088-93. PMID 20172607 DOI: 10.1016/J.Biomaterials.2010.01.136  0.349
2010 Kaneda MM, Sasaki Y, Lanza GM, Milbrandt J, Wickline SA. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. Biomaterials. 31: 3079-86. PMID 20092889 DOI: 10.1016/J.Biomaterials.2010.01.006  0.753
2010 Zhang L, Zhang H, Bibee K, Allen J, Chen J, Lanza GM, Wickline SA. Quantitative molecular imaging of atherosclerotic endothelial dysfunction with perfluorocarbon (19F) nanoparticle magnetic resonance imaging and spectroscopy Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-P120  0.781
2010 Myerson JW, Kaneda MM, Lanza GM, Wickline SA. 19F MRS assessment of siRNA delivery to vascular cells via perfluorocarbon nanoparticles Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-P103  0.824
2010 Myerson JW, He L, Tollefsen DM, Wickline SA. Thrombin inhibitor perfluorocarbon nanoparticles for treatment and 19F tracking of acute thrombosis Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-O60  0.704
2010 Caruthers SD, Senpan A, Pan D, Hu G, Wickline SA, Lanza GM. CION v2.0: A better way to T1 enhancement with iron oxides Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-O57  0.371
2010 Caruthers SD, Keupp J, Rahmer J, Lanza GM, Wickline SA. Multi-resolution simultaneous 19F/1H 3D radial imaging for self-navigated respiratory motion-corrected and quantitative imaging Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-O56  0.364
2010 Bibee K, Li A, Wickline S. Abstract P2-19-02: mTOR Pathway Inhibitor Nanoparticles Beneficially Modulate Autophagy in Triple Negative Breast Cancer Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-19-02  0.75
2010 Wallace KD, Hughes MS, Marsh JN, Caruthers SD, Lanza GM, Wickline SA. From In Vivo Ultrasound and MRI Imaging to Therapy: Contrast Agents Based on Target-Specific Nanoparticles Nanotechnology. DOI: 10.1002/9783527628155.Nanotech050  0.493
2010 Caruthers SD, Winter PM, Wickline SA, Lanza GM, Keupp J. MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles Medicamundi. 54: 5-13.  0.399
2009 Caruthers SD, Cyrus T, Winter PM, Wickline SA, Lanza GM. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 1: 311-23. PMID 20049799 DOI: 10.1002/Wnan.9  0.459
2009 Senpan A, Caruthers SD, Rhee I, Mauro NA, Pan D, Hu G, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, Lanza GM. Conquering the dark side: colloidal iron oxide nanoparticles. Acs Nano. 3: 3917-26. PMID 19908850 DOI: 10.1021/Nn900819Y  0.458
2009 Pan D, Williams TA, Senpan A, Allen JS, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. Journal of the American Chemical Society. 131: 15522-7. PMID 19795893 DOI: 10.1021/Ja906797Z  0.328
2009 Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, Arbeit JM, Wickline SA, Schlesinger PH. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. The Journal of Clinical Investigation. 119: 2830-42. PMID 19726870 DOI: 10.1172/Jci38842  0.328
2009 Pan D, Senpan A, Caruthers SD, Williams TA, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. Chemical Communications (Cambridge, England). 3234-6. PMID 19587924 DOI: 10.1039/B902875G  0.363
2009 Southworth R, Kaneda M, Chen J, Zhang L, Zhang H, Yang X, Razavi R, Lanza G, Wickline SA. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. Nanomedicine : Nanotechnology, Biology, and Medicine. 5: 359-67. PMID 19523428 DOI: 10.1016/J.Nano.2008.12.002  0.821
2009 Pan D, Pramanik M, Senpan A, Yang X, Song KH, Scott MJ, Zhang H, Gaffney PJ, Wickline SA, Wang LV, Lanza GM. Molecular photoacoustic tomography with colloidal nanobeacons. Angewandte Chemie (International Ed. in English). 48: 4170-3. PMID 19418503 DOI: 10.1002/Anie.200805947  0.425
2009 Bai MY, Cheng YJ, Wickline SA, Xia Y. Colloidal hollow spheres of conducting polymers with smooth surface and uniform, controllable sizes. Small (Weinheim An Der Bergstrasse, Germany). 5: 1747-52. PMID 19384880 DOI: 10.1002/Smll.200900447  0.496
2009 Zhou HF, Chan HW, Wickline SA, Lanza GM, Pham CT. Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2978-85. PMID 19376816 DOI: 10.1096/Fj.09-129874  0.381
2009 Pan D, Lanza GM, Wickline SA, Caruthers SD. Nanomedicine: perspective and promises with ligand-directed molecular imaging. European Journal of Radiology. 70: 274-85. PMID 19268515 DOI: 10.1016/J.Ejrad.2009.01.042  0.439
2009 Lombardi R, Rodriguez G, Chen SN, Ripplinger CM, Li W, Chen J, Willerson JT, Betocchi S, Wickline SA, Efimov IR, Marian AJ. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation. 119: 1398-407. PMID 19255346 DOI: 10.1161/Circulationaha.108.790501  0.411
2009 Kaneda MM, Caruthers S, Lanza GM, Wickline SA. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Annals of Biomedical Engineering. 37: 1922-33. PMID 19184435 DOI: 10.1007/S10439-009-9643-Z  0.788
2009 Lijowski M, Caruthers S, Hu G, Zhang H, Scott MJ, Williams T, Erpelding T, Schmieder AH, Kiefer G, Gulyas G, Athey PS, Gaffney PJ, Wickline SA, Lanza GM. High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model. Investigative Radiology. 44: 15-22. PMID 18836386 DOI: 10.1097/Rli.0B013E31818935Eb  0.436
2009 Cai K, Zhang L, Myerson J, Huang W, Caruthers SD, Lanza GM, Wickline SA, Winter PM. Dual PARACEST and 19F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles Journal of Cardiovascular Magnetic Resonance. 11. DOI: 10.1186/1532-429X-11-S1-T6  0.803
2009 Wallace K, McCarthy J, Wickerhauser V, Marsh J, Lanza G, Wickline S, Hughes M. Real-time Renyi entropy processing for molecular imaging using targeted nanoparticles. The Journal of the Acoustical Society of America. 126: 2214. DOI: 10.1121/1.3248766  0.373
2009 Cheng Y, Hughes MS, Marsh JN, Wallace KD, Wickline SA. Shannon entropy can detect myocardial anisotropy without specular echo gating in vitro. The Journal of the Acoustical Society of America. 126: 2214. DOI: 10.1121/1.3248763  0.576
2008 Erpelding TN, Caruthers SD, Wickline SA, Lanza GM. Nanotechnology in the diagnosis of atherosclerotic disease. Expert Opinion On Medical Diagnostics. 2: 635-49. PMID 23495775 DOI: 10.1517/17530059.2.6.635  0.448
2008 Winter PM, Caruthers SD, Zhang H, Williams TA, Wickline SA, Lanza GM. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. Jacc. Cardiovascular Imaging. 1: 624-34. PMID 19356492 DOI: 10.1016/J.Jcmg.2008.06.003  0.417
2008 Neubauer AM, Sim H, Winter PM, Caruthers SD, Williams TA, Robertson JD, Sept D, Lanza GM, Wickline SA. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging. Magnetic Resonance in Medicine. 60: 1353-61. PMID 19025903 DOI: 10.1002/Mrm.21795  0.823
2008 Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW. In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magnetic Resonance in Medicine. 60: 1506-11. PMID 19025893 DOI: 10.1002/Mrm.21783  0.416
2008 Neubauer AM, Myerson J, Caruthers SD, Hockett FD, Winter PM, Chen J, Gaffney PJ, Robertson JD, Lanza GM, Wickline SA. Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 1066-72. PMID 18956457 DOI: 10.1002/Mrm.21750  0.821
2008 Waters EA, Chen J, Yang X, Zhang H, Neumann R, Santeford A, Arbeit J, Lanza GM, Wickline SA. Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 1232-6. PMID 18956417 DOI: 10.1002/Mrm.21794  0.732
2008 Waters EA, Chen J, Allen JS, Zhang H, Lanza GM, Wickline SA. Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 10: 43. PMID 18817557 DOI: 10.1186/1532-429X-10-43  0.741
2008 Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, Wickline SA, Lanza GM. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 4179-89. PMID 18697838 DOI: 10.1096/Fj.08-112060  0.35
2008 Pan D, Caruthers SD, Hu G, Senpan A, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. Journal of the American Chemical Society. 130: 9186-7. PMID 18572935 DOI: 10.1021/Ja801482D  0.445
2008 Partlow KC, Lanza GM, Wickline SA. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. Biomaterials. 29: 3367-75. PMID 18485474 DOI: 10.1016/J.Biomaterials.2008.04.030  0.817
2008 Chen J, Wang Q, Zhang H, Yang X, Wang J, Berkowitz BA, Wickline SA, Song SK. In vivo quantification of T1, T2, and apparent diffusion coefficient in the mouse retina at 11.74T. Magnetic Resonance in Medicine. 59: 731-8. PMID 18383302 DOI: 10.1002/Mrm.21570  0.428
2008 Winter PM, Schmieder AH, Caruthers SD, Keene JL, Zhang H, Wickline SA, Lanza GM. Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2758-67. PMID 18362202 DOI: 10.1096/Fj.07-103929  0.4
2008 Waters EA, Wickline SA. Contrast agents for MRI. Basic Research in Cardiology. 103: 114-21. PMID 18324367 DOI: 10.1007/S00395-008-0711-6  0.684
2008 Soman NR, Lanza GM, Heuser JM, Schlesinger PH, Wickline SA. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. Nano Letters. 8: 1131-6. PMID 18302330 DOI: 10.1021/Nl073290R  0.35
2008 Cyrus T, Zhang H, Allen JS, Williams TA, Hu G, Caruthers SD, Wickline SA, Lanza GM. Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 820-6. PMID 18292395 DOI: 10.1161/Atvbaha.107.156281  0.427
2008 Caruthers SD, Senpan A, Pan D, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. 2115 A novel targeted iron oxide nanocolloid agent for rapid detection of fibrin clots via T1 and T2 weighted MRI Journal of Cardiovascular Magnetic Resonance. 10. DOI: 10.1186/1532-429X-10-S1-A384  0.37
2008 Zhang L, Chen J, Gibson A, Holland MR, Lanza GM, Wickline SA. 110 Myofiber developmental plasticity in fetal hearts delineated with diffusion tensor MRI Journal of Cardiovascular Magnetic Resonance. 10. DOI: 10.1186/1532-429X-10-S1-A11  0.391
2008 Wallace KD, Marsh JN, Thomas LJ, Neuman RG, Arbeit JM, Lanza GM, Wickline SA. Ultrasonic molecular imaging of primordial angiogenic vessels in the papilloma virus transgenic mouse with avβ3-Integrin targeted nanoparticles using renyi entropy-Based signal detection Proceedings - Ieee Ultrasonics Symposium. 367-370. DOI: 10.1109/ULTSYM.2008.0090  0.345
2008 Hughes M, Caruthers S, Tran T, Marsh J, Wallace K, Cyrus T, Partlow K, Scott M, Lijowski M, Neubauer A, Winter P, Hu G, Zhang H, McCarthy J, Maurizi B, ... ... Wickline S, et al. Perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics Proceedings of the Ieee. 96: 397-415. DOI: 10.1109/JPROC.2007.913500  0.815
2007 Tran TD, Caruthers SD, Hughes M, Marsh JN, Cyrus T, Winter PM, Neubauer AM, Wickline SA, Lanza GM. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. International Journal of Nanomedicine. 2: 515-26. PMID 18203420  0.811
2007 Cyrus T, Lanza GM, Wickline SA. Molecular imaging by cardiovascular MR. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 9: 827-43. PMID 18066742 DOI: 10.1080/10976640701693766  0.446
2007 Ripplinger CM, Li W, Hadley J, Chen J, Rothenberg F, Lombardi R, Wickline SA, Marian AJ, Efimov IR. Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation Research. 101: 1049-57. PMID 17885214 DOI: 10.1161/Circresaha.107.161240  0.412
2007 Marsh JN, Senpan A, Hu G, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis Nanomedicine. 2: 533-543. PMID 17716136 DOI: 10.2217/17435889.2.4.533  0.448
2007 Hughes MS, Marsh JN, Wallace KD, Donahue TA, Connolly AM, Lanza GM, Wickline SA. Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver. Ultrasound in Medicine & Biology. 33: 1236-43. PMID 17467153 DOI: 10.1016/J.Ultrasmedbio.2007.02.007  0.358
2007 Marsh JN, Partlow KC, Abendschein DR, Scott MJ, Lanza GM, Wickline SA. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound in Medicine & Biology. 33: 950-8. PMID 17434667 DOI: 10.1016/J.Ultrasmedbio.2006.12.007  0.82
2007 Neubauer AM, Caruthers SD, Hockett FD, Cyrus T, Robertson JD, Allen JS, Williams TD, Fuhrhop RW, Lanza GM, Wickline SA. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 9: 565-73. PMID 17365236 DOI: 10.1080/10976640600945481  0.814
2007 Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GM. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles. Expert Review of Medical Devices. 4: 137-45. PMID 17359221 DOI: 10.1586/17434440.4.2.137  0.626
2007 Wickline SA, Neubauer AM, Winter PM, Caruthers SD, Lanza GM. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. Journal of Magnetic Resonance Imaging : Jmri. 25: 667-80. PMID 17347992 DOI: 10.1002/Jmri.20866  0.813
2007 Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1647-54. PMID 17284484 DOI: 10.1096/Fj.06-6505Com  0.806
2007 Hu G, Lijowski M, Zhang H, Partlow KC, Caruthers SD, Kiefer G, Gulyas G, Athey P, Scott MJ, Wickline SA, Lanza GM. Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles. International Journal of Cancer. Journal International Du Cancer. 120: 1951-7. PMID 17278104 DOI: 10.1002/Ijc.22581  0.797
2007 Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Current Opinion in Biotechnology. 18: 26-30. PMID 17254762 DOI: 10.1016/J.Copbio.2007.01.006  0.343
2007 Lanza G, Winter P, Cyrus T, Caruthers S, Marsh J, Hughes M, Wickline S. Nanomedicine opportunities in cardiology. Annals of the New York Academy of Sciences. 1080: 451-65. PMID 17132801 DOI: 10.1196/Annals.1380.034  0.378
2007 Partlow KC, Brant JA, Marsh JN, Nolta JA, Hughes MS, Lanza GM, Wickline SA. Ultrasound energy rapidly labels stem/progenitor cells with nanoparticle beacons without disrupting membrane integrity Proceedings - Ieee Ultrasonics Symposium. 1768-1771. DOI: 10.1109/ULTSYM.2007.445  0.8
2007 Partlow KC, Brant JA, Marsh JN, Nolta JA, Hughes MS, Lanza GM, Wickline SA. Ultrasound energy markedly and rapidly effects stem/progenitor cell labeling with nanoparticle beacons for molecular imaging and cell tracking The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A379-B  0.81
2007 Soman NR, Lanza GM, Schlesinger PH, Wickline SA. Novel approach for specific delivery of cytolytic peptides (melittin) to cancer cells using molecularly targeted perfluorocarbon nanoparticles The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A31-A  0.389
2007 Cyrus T, Caruthers SD, Wickline SA, Lanza GM. Nanoparticles for Magnetic Resonance Imaging of Tumors Nanotechnologies For the Life Sciences. DOI: 10.1002/9783527610419.Ntls0074  0.462
2007 Winter PM, Caruthers SD, Lanza GM, Wickline SA. Diagnostic and Therapeutic Targeted Perfluorocarbon Nanoparticles Nanobiotechnology Ii: More Concepts and Applications. 365-380. DOI: 10.1002/9783527610389.ch19  0.333
2006 Lanza GM, Winter PM, Caruthers SD, Hughes MS, Cyrus T, Marsh JN, Neubauer AM, Partlow KC, Wickline SA. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomedicine (London, England). 1: 321-9. PMID 17716162 DOI: 10.2217/17435889.1.3.321  0.799
2006 Winter PM, Cai K, Chen J, Adair CR, Kiefer GE, Athey PS, Gaffney PJ, Buff CE, Robertson JD, Caruthers SD, Wickline SA, Lanza GM. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 56: 1384-8. PMID 17089356 DOI: 10.1002/Mrm.21093  0.712
2006 Hughes MS, Marsh JN, Zhang H, Woodson AK, Allen JS, Lacy EK, Carradine C, Lanza GM, Wickline SA. Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 53: 1609-16. PMID 16964911 DOI: 10.1109/TUFFC.2006.1678189  0.319
2006 Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Zhang H, Wickline SA, Lanza GM. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 2103-9. PMID 16825592 DOI: 10.1161/01.Atv.0000235724.11299.76  0.808
2006 Soman NR, Marsh JN, Hughes MS, Lanza GM, Wickline SA. Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity. Ieee Transactions On Nanobioscience. 5: 69-75. PMID 16805101 DOI: 10.1109/Tnb.2006.875052  0.458
2006 Cyrus T, Abendschein DR, Caruthers SD, Harris TD, Glattauer V, Werkmeister JA, Ramshaw JA, Wickline SA, Lanza GM. MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 8: 535-41. PMID 16755843 DOI: 10.1080/10976640600580296  0.474
2006 Liu W, Ashford MW, Chen J, Watkins MP, Williams TA, Wickline SA, Yu X. MR tagging demonstrates quantitative differences in regional ventricular wall motion in mice, rats, and men. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2515-21. PMID 16751290 DOI: 10.1152/Ajpheart.01016.2005  0.445
2006 Winter PM, Caruthers SD, Wickline SA, Lanza GM. Molecular imaging by MRI. Current Cardiology Reports. 8: 65-9. PMID 16507239 DOI: 10.1007/S11886-006-0013-2  0.436
2006 Caruthers SD, Winter PM, Wickline SA, Lanza GM. Targeted magnetic resonance imaging contrast agents. Methods in Molecular Medicine. 124: 387-400. PMID 16506431 DOI: 10.1385/1-59745-010-3:387  0.472
2006 Caruthers SD, Neubauer AM, Hockett FD, Lamerichs R, Winter PM, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Investigative Radiology. 41: 305-12. PMID 16481914 DOI: 10.1097/01.Rli.0000199281.60135.6A  0.829
2006 Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G. Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 435-41. PMID 16373609 DOI: 10.1161/01.Atv.0000201069.47550.8B  0.761
2006 Raju BI, Hall CS, Hughes MS, Wickline SA, Lanza GM. Ultrasound‐mediated nanoparticle drug delivery in an invivo tumor model Journal of the Acoustical Society of America. 120: 3003-3003. DOI: 10.1121/1.4787005  0.445
2006 Wallace KD, Hughes MS, Marsh JN, Crowder KC, Zhang H, Wickline SA, Lanza GM. Molecular imaging and therapy with perfluorocarbon‐based site targeted contrast nanoparticles The Journal of the Acoustical Society of America. 119: 3438-3438. DOI: 10.1121/1.4786922  0.495
2006 Neumann R, Olson K, Lanza G, Wickline S, Arbeit J. Targeted nanoparticle imaging of angiogenic endothelial activation in premalignant neoplasia and established epithelial cancers Journal of the American College of Surgeons. 203: S83. DOI: 10.1016/J.Jamcollsurg.2006.05.216  0.422
2006 Marsh J, Hughes M, Gaffney P, Scott M, Wickline S, Lanza G. CMR 2005: 8.02: Fibrin-directed nanoparticles for combined imaging and local thrombolytic therapy Contrast Media & Molecular Imaging. 1: 73-73. DOI: 10.1002/cmmi.47  0.321
2006 Cyrus T, Caruthers S, Harris T, Glattauer V, Werkmeister J, Ramshaw J, Wickline S, Lanza G. CMR 2005: 4.02: Targeted MR nanoparticles for local anti-restenotic therapy following angioplasty Contrast Media & Molecular Imaging. 1: 62-62. DOI: 10.1002/cmmi.24  0.307
2006 Lanza GM, Winter PM, Hughes MS, Caruthers SD, Marsh JN, Morawski AM, Schmieder AH, Scott MJ, Fuhrhop RW, Zhang H, Hu G, Lacy EK, Allen JS, Wickline SA. Molecular imaging and therapy: New paradigms for 21 st century medicine Acs Symposium Series. 923: 295-311.  0.342
2005 Crowder KC, Hughes MS, Marsh JN, Barbieri AM, Fuhrhop RW, Lanza GM, Wickline SA. Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery. Ultrasound in Medicine & Biology. 31: 1693-700. PMID 16344131 DOI: 10.1016/J.Ultrasmedbio.2005.07.022  0.463
2005 Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockett FD, Wickline SA. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Current Topics in Developmental Biology. 70: 57-76. PMID 16338337 DOI: 10.1016/S0070-2153(05)70003-X  0.83
2005 Chen J, Liu W, Zhang H, Lacy L, Yang X, Song SK, Wickline SA, Yu X. Regional ventricular wall thickening reflects changes in cardiac fiber and sheet structure during contraction: quantification with diffusion tensor MRI. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1898-907. PMID 16219812 DOI: 10.1152/Ajpheart.00041.2005  0.393
2005 Winter PM, Shukla HP, Caruthers SD, Scott MJ, Fuhrhop RW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM. Molecular imaging of human thrombus with computed tomography. Academic Radiology. 12: S9-13. PMID 16106538 DOI: 10.1016/J.Acra.2005.02.016  0.301
2005 Cyrus T, Winter PM, Caruthers SD, Wickline SA, Lanza GM. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy. Expert Review of Cardiovascular Therapy. 3: 705-15. PMID 16076280 DOI: 10.1586/14779072.3.4.705  0.515
2005 Waters EA, Caruthers SD, Wickline SA. Correlation analysis of stenotic aortic valve flow patterns using phase contrast MRI. Annals of Biomedical Engineering. 33: 878-87. PMID 16060527 DOI: 10.1007/S10439-005-2865-9  0.633
2005 Hughes MS, Marsh JN, Hall CS, Fuhrhop RW, Lacy EK, Lanza GM, Wickline SA. Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging. The Journal of the Acoustical Society of America. 117: 964-72. PMID 15759715 DOI: 10.1121/1.1810251  0.417
2005 Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 53: 621-7. PMID 15723405 DOI: 10.1002/Mrm.20391  0.444
2005 Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Current Opinion in Biotechnology. 16: 89-92. PMID 15722020 DOI: 10.1016/J.Copbio.2004.11.001  0.465
2005 Hughes MS, Crowder KC, Lanza GM, Wickline SA. Augmented and selective delivery of liquid perfluorocarbon nanoparticles to melanoma cells with ultrasound Journal of the Acoustical Society of America. 117: 2472-2472. DOI: 10.1121/1.4809416  0.457
2005 Hughes M, Marsh JN, Arbeit J, Neumann R, Fuhrhop RW, Lanza GM, Wickline SA. Ultrasonic molecular imaging of primordial angiogenic vessels in rabbit and mouse models with αvβ3-integrin targeted nanoparticles using information-theoretic signal detection: Results at high frequency and in the clinical diagnostic frequency range Proceedings - Ieee Ultrasonics Symposium. 1: 617-620. DOI: 10.1109/ULTSYM.2005.1602928  0.371
2005 Lanza GM, Hughes MS, Marsh JN, Scott MJ, Zhang H, Lacy EK, Allen JS, Wickline SA. Acoustic molecular imaging and targeted drug delivery with perfluorocarbon nanoparticles Aip Conference Proceedings. 754: 120-123. DOI: 10.1063/1.1901616  0.352
2005 Winter P, Athey P, Kiefer G, Gulyas G, Frank K, Fuhrhop R, Robertson D, Wickline S, Lanza G. Improved paramagnetic chelate for molecular imaging with MRI Journal of Magnetism and Magnetic Materials. 293: 540-545. DOI: 10.1016/J.Jmmm.2005.01.062  0.426
2005 Winter PM, Caruthers SD, Harris TD, Schmeider AH, Abendschein D, Cyrus T, Fuhrhop R, Dietz E, Williams TA, Allen JS, Zhang H, Wickline SA, Lanza GM. Molecular Imaging of αvβ3-Integrin: An Opportune Biochemical Signature For Oncologic and Cardiovascular Diseases Academic Radiology. 12: S43. DOI: 10.1016/J.Acra.2005.02.030  0.479
2005 Robertson JD, Crane SB, Wickline SA, Lanza GM. Characterization and biodistribution of a novel MRI molecular imaging agent by neutron activation analysis Journal of Radioanalytical and Nuclear Chemistry. 263: 511-514. DOI: 10.1007/S10967-005-0084-3  0.492
2004 Lanza GM, Winter PM, Caruthers SD, Morawski AM, Schmieder AH, Crowder KC, Wickline SA. Magnetic resonance molecular imaging with nanoparticles. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 11: 733-43. PMID 15592197 DOI: 10.1016/J.Nuclcard.2004.09.002  0.459
2004 Lanza GM, Winter P, Caruthers S, Schmeider A, Crowder K, Morawski A, Zhang H, Scott MJ, Wickline SA. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Current Pharmaceutical Biotechnology. 5: 495-507. PMID 15579039 DOI: 10.2174/1389201043376544  0.412
2004 Liu W, Chen J, Ji S, Allen JS, Bayly PV, Wickline SA, Yu X. Harmonic phase MR tagging for direct quantification of Lagrangian strain in rat hearts after myocardial infarction. Magnetic Resonance in Medicine. 52: 1282-90. PMID 15562486 DOI: 10.1002/Mrm.20276  0.431
2004 Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SA. Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted 19F nanoparticles Magnetic Resonance in Medicine. 52: 1255-1262. PMID 15562481 DOI: 10.1002/Mrm.20287  0.493
2004 Lin SJ, Brown PA, Watkins MP, Williams TA, Lehr KA, Liu W, Lanza GM, Wickline SA, Caruthers SD. Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. Journal of the American College of Cardiology. 44: 133-7. PMID 15234421 DOI: 10.1016/J.Jacc.2004.03.038  0.307
2004 Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magnetic Resonance in Medicine. 51: 480-6. PMID 15004788 DOI: 10.1002/Mrm.20010  0.504
2004 Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Current Problems in Cardiology. 28: 625-53. PMID 14691443 DOI: 10.1016/J.Cpcardiol.2003.11.001  0.361
2004 Hughes MS, Marsh JN, Allen J, Brown PA, Lacy EK, Scott MJ, Lanza GM, Wickline SA, Hall CS. In vivo ultrasonic detection of angiogenesis with site-targeted nanoparticle contrast agents using measure-theoretic signal receivers Proceedings - Ieee Ultrasonics Symposium. 2: 1106-1109. DOI: 10.1109/ULTSYM.2004.1417973  0.323
2004 Marsh JN, Crowder KC, Hughes MS, Scott MJ, Lacy EK, Lanza GM, Wickline SA. In vitro acoustic molecular imaging of tissue factor expressed by smooth muscle cells with stable liquid perfluorocarbon nanoparticle contrast agents Proceedings - Ieee Ultrasonics Symposium. 2: 1102-1105. DOI: 10.1109/ULTSYM.2004.1417972  0.306
2004 Winter PM, Morawski AM, Caruthers SD, Harris TD, Fuhrhop RW, Zhang H, Allen JS, Lacy EK, Williams TA, Wickline SA, Lanza GM. 1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic α ν β 3 -integrin-targeted fumagillin nanoparticles Journal of the American College of Cardiology. 43: A322-A323. DOI: 10.1016/S0735-1097(04)91363-0  0.347
2003 Caruthers SD, Lin SJ, Brown P, Watkins MP, Williams TA, Lehr KA, Wickline SA. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation. 108: 2236-43. PMID 14568899 DOI: 10.1161/01.Cir.0000095268.47282.A1  0.318
2003 Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 108: 2270-4. PMID 14557370 DOI: 10.1161/01.Cir.0000093185.16083.95  0.377
2003 Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Research. 63: 5838-43. PMID 14522907  0.332
2003 Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM. Improved molecular imaging contrast agent for detection of human thrombus. Magnetic Resonance in Medicine. 50: 411-6. PMID 12876719 DOI: 10.1002/Mrm.10532  0.56
2003 Chen J, Song SK, Liu W, McLean M, Allen JS, Tan J, Wickline SA, Yu X. Remodeling of cardiac fiber structure after infarction in rats quantified with diffusion tensor MRI. American Journal of Physiology. Heart and Circulatory Physiology. 285: H946-54. PMID 12763752 DOI: 10.1152/Ajpheart.00889.2002  0.413
2003 Wickline SA, Lanza GM. Molecular imaging, targeted therapeutics, and nanoscience. Journal of Cellular Biochemistry. Supplement. 39: 90-7. PMID 12552608 DOI: 10.1002/Jcb.10422  0.396
2003 Wickline SA, Sahn DJ, Kerber R, Reichek N, Pennell DJ. Report from the First International Conjoint Conference on Cardiovascular Magnetic Resonance and Echocardiography. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 4: 515-20. PMID 12549239 DOI: 10.1081/Jcmr-120016390  0.345
2003 Jiuan Lin S, Watkins MP, Williams T, Brown PA, Lehr KA, Lenza GM, Wickline SA, Caruthers SD. Quantitative magnetic resonance valve imaging: An accurate tool for evaluating mitral stenosis Journal of the American College of Cardiology. 41: 417-418. DOI: 10.1016/S0735-1097(03)81233-0  0.33
2003 Crowder KC, Hughes MS, Marsh JN, Scott MJ, Chinen L, Harris TD, Lanza GM, Wickline SA. First experience with noncavitational ultrasound enhancement of selective cellular delivery of liquid perfluorocarbon nanoparticles to Angiogenic sites Journal of the American College of Cardiology. 41: 59. DOI: 10.1016/S0735-1097(03)80867-7  0.392
2002 Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis Circulation. 106: 2842-2847. PMID 12451012 DOI: 10.1161/01.Cir.0000044020.27990.32  0.496
2002 Lanza GM, Abendschein DR, Yu X, Winter PM, Karukstis KK, Scott MJ, Fuhrhop RW, Scherrer DE, Wickline SA. Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology Academic Radiology. 9: S330-S331. PMID 12188265 DOI: 10.1016/S1076-6332(03)80220-9  0.439
2002 Wickline SA, Hughes M, Ngo FC, Hall CS, Marsh JN, Brown PA, Allen JS, McLean MD, Scott MJ, Fuhrhop RW, Lanza GM. Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent. Academic Radiology. 9: S290-3. PMID 12188251 DOI: 10.1016/S1076-6332(03)80206-4  0.474
2002 Marsh JN, Hall CS, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, Lanza GM. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 49: 29-38. PMID 11833889 DOI: 10.1109/58.981381  0.309
2002 Lanza GM, Abendschein DR, Yu X, Winter PM, Scott MJ, Fuhrhop RW, Scherrer DE, Wickline SA. Magnetic resonance imaging and quantification of targeted drug delivery to vascular cells with paramagnetic perfluorocarbon nanoparticles Journal of the American College of Cardiology. 39: 390. DOI: 10.1016/S0735-1097(02)81752-1  0.468
2002 Caruthers SD, Lin R, Watkins MP, Brown P, Lehr K, McKinney L, Lanza GM, Wickline SA. Is magnetic resonance imaging a reliable tool for quantifying aortic valve stenosis? Journal of the American College of Cardiology. 39: 368. DOI: 10.1016/S0735-1097(02)81655-2  0.318
2001 Hall CS, Marsh JN, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent. The Journal of the Acoustical Society of America. 110: 1677-84. PMID 11572376 DOI: 10.1121/1.1395584  0.404
2001 Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 104: 1280-5. PMID 11551880 DOI: 10.1161/Hc3601.094303  0.403
2001 Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Progress in Cardiovascular Diseases. 44: 13-31. PMID 11533924 DOI: 10.1053/Pcad.2001.26440  0.362
2000 Hall CS, Marsh JN, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent. The Journal of the Acoustical Society of America. 108: 3049-57. PMID 11144597 DOI: 10.1121/1.1322566  0.436
2000 Yu X, Song SK, Chen J, Scott MJ, Fuhrhop RJ, Hall CS, Gaffney PJ, Wickline SA, Lanza GM. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magnetic Resonance in Medicine. 44: 867-72. PMID 11108623 DOI: 10.1002/1522-2594(200012)44:6<867::Aid-Mrm7>3.0.Co;2-P  0.558
2000 Chia JM, Fischer SE, Wickline SA, Lorenz CH. Performance of QRS detection for cardiac magnetic resonance imaging with a novel vectorcardiographic triggering method. Journal of Magnetic Resonance Imaging : Jmri. 12: 678-88. PMID 11050637 DOI: 10.1002/1522-2586(200011)12:5<678::Aid-Jmri4>3.0.Co;2-5  0.314
2000 Ferrara KW, Merritt CR, Burns PN, Foster FS, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Academic Radiology. 7: 824-39. PMID 11048880 DOI: 10.1016/S1076-6332(00)80631-5  0.346
2000 Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 44: 433-9. PMID 10975896 DOI: 10.1002/1522-2594(200009)44:3<433::Aid-Mrm14>3.0.Co;2-9  0.399
2000 Lanza GM, Abendschein DR, Hall CS, Scott MJ, Scherrer DE, Houseman A, Miller JG, Wickline SA. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 13: 608-14. PMID 10849515 DOI: 10.1067/Mje.2000.105840  0.394
2000 Lanza GM, Abendschein DR, Hall CS, Marsh JN, Scott MJ, Scherrer DE, Wickline SA. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Investigative Radiology. 35: 227-34. PMID 10764091 DOI: 10.1097/00004424-200004000-00003  0.407
1999 Johansson LO, Nolan MM, Taniuchi M, Fischer SE, Wickline SA, Lorenz CH. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 1: 139-43. PMID 11550346 DOI: 10.3109/10976649909080842  0.31
1999 Hofman MB, Henson RE, Kovács SJ, Fischer SE, Lauffer RB, Adzamli K, De Becker J, Wickline SA, Lorenz CH. Blood pool agent strongly improves 3D magnetic resonance coronary angiography using an inversion pre-pulse. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 41: 360-7. PMID 10080285 DOI: 10.1002/(Sici)1522-2594(199902)41:2<360::Aid-Mrm21>3.0.Co;2-C  0.317
1998 Lanza GM, Trousil RL, Wallace KD, Rose JH, Hall CS, Scott MJ, Miller JG, Eisenberg PR, Gaffney PJ, Wickline SA. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. The Journal of the Acoustical Society of America. 104: 3665-72. PMID 9857523 DOI: 10.1121/1.423948  0.352
1998 Hofman MB, Adzamli K, Allen JS, Fischer SE, Brown JJ, Adams MD, Wickline SA, Lorenz CH. Kinetics of a novel blood pool agent (MP-2269) with persistent high relaxivity for MR angiography. Academic Radiology. 5: S206-9; discussion S. PMID 9561082 DOI: 10.1016/S1076-6332(98)80107-4  0.335
1998 Lanza GM, Lorenz CH, Fischer SE, Scott MJ, Cacheris WP, Kaufmann RJ, Gaffney PJ, Wickline SA. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Academic Radiology. 5: S173-6; discussion S. PMID 9561074 DOI: 10.1016/S1076-6332(98)80097-4  0.403
1998 Lanza GM, Wallace KD, Trousil RL, Miller JG, Rose JH, Gaffney PJ, Abendschein DR, Hall CS, Scott MJ, Lorenz CA, Fuhrhop R, Wickline SA. Targeted acoustic contrast agents: New opportunities for ultrasound in medical diagnosis and therapy The Journal of the Acoustical Society of America. 103: 3002-3002. DOI: 10.1121/1.421736  0.351
1998 Lanza G, Abendschein D, Hall C, Scherrer D, Scott M, Houseman A, Miller J, Wickline S. In situ localization of tissue-factor following carotid angioplasty using a ligand-targeted ultrasonic contrast agent and intravascular ultrasound Journal of the American College of Cardiology. 31: 19. DOI: 10.1016/S0735-1097(98)80734-1  0.323
1997 Wickline SA. Advances in Ultrasound Methods for High-Resolution Imaging of the Cardiovascular System Trends in Cardiovascular Medicine. 7: 168-174. PMID 21235881 DOI: 10.1016/S1050-1738(97)00031-5  0.36
1997 Lanza GM, Wallace KD, Fischer SE, Christy DH, Scott MJ, Trousil RL, Cacheris WP, Miller JG, Gaffney PJ, Wickline SA. High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound in Medicine & Biology. 23: 863-70. PMID 9300990 DOI: 10.1016/S0301-5629(97)00046-X  0.359
1996 Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 94: 3334-40. PMID 8989148 DOI: 10.1161/01.Cir.94.12.3334  0.394
1996 Lanza GM, Wallace KD, Scott MJ, Trousil RL, Miller JG, Gaffney PJ, Wickline SA. Development of a site targeted acoustic contrast agent for improved medical ultrasonic diagnosis The Journal of the Acoustical Society of America. 100: 2617-2617. DOI: 10.1121/1.417678  0.384
1996 Lorenz CH, Harris PA, Overholser KA, Fischer SE, Wickline SA. MYOCARDIAL PERFUSION IMAGING WITH AN EXTRAVASCULAR CONTRAST AGENT Asaio Journal. 42: 128. DOI: 10.1097/00002480-199603000-00424  0.373
1996 Lanza GM, Wallace KD, Christy D, Miller JG, Wickline SA. A Novel Site -Targeted Ultrasonic Contrast Agent For Specific Detection of Molecular Ligands Asaio Journal. 42: 128. DOI: 10.1097/00002480-199603000-00422  0.33
1996 Lanza GM, Wallace KD, Eisenberg PR, Scott MJ, Cacheris WP, Christy DH, Sharkey AM, Miller JG, Wickline SA. Novel ultrasonic contrast agent targeted to D-dimer using DD-3B6 monoclonal F(ab) in vitro Journal of the American College of Cardiology. 27: 243. DOI: 10.1016/S0735-1097(96)81847-X  0.335
1994 Recchia D, Wickline SA. Ultrasonic tissue characterization of blood during stasis and thrombosis with a real-time linear-array backscatter imaging system. Coronary Artery Disease. 4: 987-94. PMID 8173716 DOI: 10.1097/00019501-199311000-00006  0.358
1993 Recchia D, Miller JG, Wickline SA. Quantification of ultrasonic anisotropy in normal myocardium with lateral gain compensation of two-dimensional integrated backscatter images. Ultrasound in Medicine & Biology. 19: 497-505. PMID 8236591 DOI: 10.1016/0301-5629(93)90125-8  0.315
1993 Miller JG, Wickline SA, Perez JE, Barzilai B, Holland MR, Handley SM, Sobel BE. Quantitative ultrasonic imaging for tissue characterization The Journal of the Acoustical Society of America. 94: 1810-1810. DOI: 10.1121/1.407843  0.336
1992 Pérez JE, Miller JG, Wickline SA, Holland MR, Waggoner AD, Barzilai B, Sobel BE. Quantitative ultrasonic imaging: tissue characterization and instantaneous quantification of cardiac function. The American Journal of Cardiology. 69: 104H-111H. PMID 1605115 DOI: 10.1016/0002-9149(92)90653-G  0.354
1992 Wickline SA, Perez JE, Barzilai B, Sobel BE, Miller JG. Characterization of cardiovascular tissue with ultrasonic backscatter. The Journal of the Acoustical Society of America. 91: 2407-2407. DOI: 10.1121/1.403246  0.338
Show low-probability matches.